2020
DOI: 10.1016/j.ejphar.2020.172960
|View full text |Cite
|
Sign up to set email alerts
|

Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…Other compounds with antioxidant potential have demonstrated nephroprotective effects in experimental models of diabetes, both of natural [ 33 ] and pharmacological [ 34 ] origin. This antioxidant potential is of fundamental importance in explaining the nephroprotection of hydroxytyrosol at a morphological and functional level.…”
Section: Discussionmentioning
confidence: 99%
“…Other compounds with antioxidant potential have demonstrated nephroprotective effects in experimental models of diabetes, both of natural [ 33 ] and pharmacological [ 34 ] origin. This antioxidant potential is of fundamental importance in explaining the nephroprotection of hydroxytyrosol at a morphological and functional level.…”
Section: Discussionmentioning
confidence: 99%
“…Levosimendan, a positive inotropic drug approved to increase cardiac contractility and management of decompensated heart failure. Indeed, earlier research has reported the ability of levosimendan against Parkinson's disease [12], mild septic encephalopathy [13], ototoxicity [14], nephrotoxicity [15], tauoligomerisation inhibition in brain cells of Tau P301L -BiFC mice [16] and other attributes include anti-oxidant and anti-in ammatory effects [17][18][19]. The cardioprotective effects and vasodilatory actions Levosimendan are mediated by calcium sensitization of contractile proteins and opening of ATPdependent K + channels in vascular smooth muscle cells and cardiac mitochondria [20][21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%